Press Release

Updates and news NEWS SHIFTBIO INC. has received "Ministry of SMEs and Startup Business Award"

Updates and news NEWS Dr. In-San Kim, a co-founder of SHIFTBIO INC., has been invited as a speaker to the ANSEV 2023 Conference

Updates and news NEWS Dr. Gi-Hoon Nam joined as a speaker at two of the largest startup events in the country

Updates and news NEWS SHIFTBIO INC. is thrilled to join the Seoul-Basel Start-up program this November!

Updates and news NEWS Dr. Gi-Hoon Nam, CEO of SHIFTBIO INC.: Invited as a speaker at the '2023 Biopharma Open Innovation'.

Updates and news NEWS Dr. Gi-Hoon Nam joined as a speaker at 'The 24th World Knowledge Forum'

Updates and news NEWS Dr. Gi-Hoon Nam, CEO of SHIFTBIO: Joined two consecutive years as speaker at 'The 5th Exosome Based Therapeutic Development Summit' in Boston

Updates and news NEWS [Triumphant Success at Korea Conference] A Star Wars of Startups

Updates and news NEWS SHIFTBIO INC. has initiated a joint research collaboration with the global enterprise Dassault Systems on an “AI-driven Cell-Free Nanotherapy Platform Technology.”

Updates and news NEWS SHIFTBIO INC. has been chosen to join President Yoon Suk-yeol's business delegation to the United States

Updates and news NEWS '2023 Hongneung Innovative Bio Forum'

Updates and news NEWS Happy New Year from SHIFTBIO

Updates and news NEWS "The communication tools between cells can be used as therapeutics."

Updates and news NEWS Congratulations on the second foundation anniversary of SHIFTBIO INC.

Updates and news NEWS Dr. In-San Kim, a co-founder of SHIFTBIO INC., has been appointed as a fellow researcher at the Korea Institute of Science and Technology (KIST)

Updates and news NEWS "Why to use EVs as the CD47 blockade?"

Updates and news NEWS SHIFTBIO INC. announced the detailed realization plan upon The SBI-102 and the Intrinsic Nanovesicle-based platform technology

Updates and news NEWS SHIFTBIO INC. and RoosterBio had a valuable discussion on the large-scale production process development of SHIFTBIO INC’s main pipeline, SBI-102, along with innovative business models

Updates and news NEWS Dr. Gi-Hoon Nam, Co-Founder of SHIFTBIO INC, has joined as a panelist at the 23rd World Knowledge Forum

Updates and news NEWS “SHIFTBIO INC., a company that puts the armor on the avatar of cells”

Updates and news NEWS SHIFTBIO INC. attended the GLOBAL INVESTMENT SUMMIT 2022

Updates and news NEWS Korea’s leading media group, JoongAng News interviewed SHIFTBIO

Updates and news NEWS Thomas M. Roberts and Kenneth W. Witwer became the first two official ShiftBio Scientific Advisory Board members!

Updates and news ShiftBio Co., Ltd. Selected as 2022 'First Penguin' by KODIT

Updates and news NEWS ShiftBio Partners with RoosterBio Inc. to Develop SBI-102 for Rare Diseases and Cancer

Updates and news ShiftBio presented at the 2022 Korea Conference in Los Angeles, USA!

Updates and news NEWS In-San Kim, MD, Ph.D. featured on the International Society for Extracellular Vesicles (ISEV) eNEWs